Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101).
about
Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant StrategiesAnoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis.DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study.
P2860
Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101).
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacokinetic Study of Adjuv ...... Major Hepatectomy (KHBO1101).
@ast
Pharmacokinetic Study of Adjuv ...... Major Hepatectomy (KHBO1101).
@en
type
label
Pharmacokinetic Study of Adjuv ...... Major Hepatectomy (KHBO1101).
@ast
Pharmacokinetic Study of Adjuv ...... Major Hepatectomy (KHBO1101).
@en
prefLabel
Pharmacokinetic Study of Adjuv ...... Major Hepatectomy (KHBO1101).
@ast
Pharmacokinetic Study of Adjuv ...... Major Hepatectomy (KHBO1101).
@en
P2093
P2860
P1433
P1476
Pharmacokinetic Study of Adjuv ...... g Major Hepatectomy (KHBO1101)
@en
P2093
Akinobu Hamada
Etsuo Hatano
Hiroaki Nagano
Hironobu Minami
Kenichi Yoshimura
Masanori Toyoda
Masashi Kanai
Shogo Kobayashi
Tatsuya Ioka
Tetsuo Ajiki
P2860
P304
P356
10.1371/JOURNAL.PONE.0143072
P407
P577
2015-12-03T00:00:00Z